Experiments for taxon Aspergillus ochraceus (HYPHOMYCETES)

Experiments (30 results)

Filters
Worktypes (27)
10
10
8
8
7
6
5
4
4
3
3
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
No match
Pharmacology (7)
2
1
1
1
1
1
23
No match
Compounds (19)
9
3
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
No match
Organisms (21)
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
30 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
923951
MICROBIAL TRANSFORMATION OF
Aspergillus ochraceus (HYPHOMYCETES)
RETINOIC ACID
993558
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A
855592
ISOLATION AND IDENTIFICATION OF
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A
915407
PHARMACOLOGY OF COMPOUND - IN VIVO
DIABETOGENIC ACTIVITY
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A
6107
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)INFRARED SPECTRUM REPORTED FOR
LARVICIDAL ACTIVITY
Aspergillus ochraceus (HYPHOMYCETES)
ASPOCHRACIN
948511
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Aspergillus ochraceus (HYPHOMYCETES)
767983
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus ochraceus (HYPHOMYCETES)
DIAPORTHINORTHOSPORIN
915406
ISOLATION AND IDENTIFICATION OF
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A
130497
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDAMINO ACID ANALYSIS OFQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus ochraceus (HYPHOMYCETES)
AMAUROMINE,EPI: N-METHYL:
1169880
PHARMACOLOGY OF EXTRACT - IN VIVO
TOXIC EFFECT(GENERAL)
Aspergillus ochraceus (HYPHOMYCETES)
235074
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Aspergillus ochraceus (HYPHOMYCETES)
CIRCUMDATIN F
317556
MICROBIAL TRANSFORMATION OF
Aspergillus ochraceus (HYPHOMYCETES)
CYPERONE,ALPHA: (+):
331890
PATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Aspergillus ochraceus (HYPHOMYCETES)
PHENYLALANINE,L: 3-4-DIHYDROXY: N-PHENYL-ACETYL:
330478
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Aspergillus ochraceus (HYPHOMYCETES)
SECALONIC ACID
858830
PLANT TISSUE CULTURE MARKER CODEMICROBIAL TRANSFORMATION OF
Aspergillus ochraceus (HYPHOMYCETES)
PRIMAQUINE,4-METHYL:
130498
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus ochraceus (HYPHOMYCETES)
AMAUROMINE,EPI:
1169881
ISOLATION AND IDENTIFICATION OF
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A
235073
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Aspergillus ochraceus (HYPHOMYCETES)
CIRCUMDATIN E
322544
IDENTIFICATION OFQUANTITATIVE DATA REPORTEDTOXICITY MARKER CODETLC DATA REPORTED
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A
994749
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A
5750
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDAMINO ACID ANALYSIS OFQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus ochraceus (HYPHOMYCETES)
ASPOCHRACIN
809940
PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODE
TERATOGENIC ACTIVITY
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A
5659
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)INFRARED SPECTRUM REPORTED FOR
ANTIANOPHELES ACTIVITY
Aspergillus ochraceus (HYPHOMYCETES)
ASPOCHRACIN
130499
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Aspergillus ochraceus (HYPHOMYCETES)
CYCLOECHINULIN
858831
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Aspergillus ochraceus (HYPHOMYCETES)
PRIMAQUINE,4-METHYL: DEAMINO: CARBOXY:
235072
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
Aspergillus ochraceus (HYPHOMYCETES)
CIRCUMDATIN D
331889
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Aspergillus ochraceus (HYPHOMYCETES)
TYROSINE,L: N-PHENYL-ACETYL:
335781
CARCINOGENIC DATA (MARKER CODE)QUANTITATIVE DATATOXICITY MARKER CODEMICROBIAL DEGRADATION OF
Aspergillus ochraceus (HYPHOMYCETES)
89212
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Aspergillus ochraceus (HYPHOMYCETES)
FERRIRHODIN,DE-(DISERYL-GLYCYL):
1169882
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXIC EFFECT(GENERAL)
Aspergillus ochraceus (HYPHOMYCETES)
OCHRATOXIN A